期刊文献+

电针与帕罗西汀治疗脑卒中后抑郁症33例临床观察 被引量:4

Clinical Observation of Combined Acupuncture and Paroxetine in Treating 33 Cases of Post-stroke Depression
下载PDF
导出
摘要 目的观察电针与药物结合治疗脑卒中后抑郁症(PSD)的临床疗效。方法将33例PSD患者随机分为治疗组(17例)和对照组(16例),治疗组采用电针加帕罗西汀治疗,对照组单纯采用帕罗西治疗,治疗6周后观察两组的临床疗效。结果治疗组总有效率为88.2%,对照组为62.5%,治疗组疗效优于对照组(P<0.01);两组治疗后汉密顿抑郁量表(HAMD)评分均较治疗前显著降低(P<0.01),且治疗组HAMD评分明显低于对照组(P<0.01)。结论电针与药物结合治疗PSD的疗效显著,值得临床推广使用。 Objective To observe the clinical efficacy of acupuncture and medicine in the treatment of post-stroke depression(PSD).Methods 33 cases were randomized into treatment group in which 17 cases were treated with acupuncture and paroxetine,and control group in which 16 cases were treated with paroxetine alone,with a course of 6 weeks.Results The total effective rate was 88.2% in the treatment group and 62.5% in the control group,with a statistically significant difference between them(P0.01);after treatment,the hamilton depression scale(HAMD)scores were obviously reduced in both groups(P0.01),with a more significant reduction in the treatment group HAMD than in the control group(P0.01).Conclusion Combined acupuncture and medicine has excellent results in the treatment of PSD,which is worth of clinical use.
出处 《医学综述》 2012年第6期950-951,共2页 Medical Recapitulate
关键词 脑卒中 抑郁症 电针与药物结合 疗效观察 Stroke Depression Combined acupuncture and medicine Clinical observation
  • 相关文献

参考文献3

二级参考文献67

  • 1孙学礼,黄明生,唐向东,杨怀瑜,严军.帕罗西丁、舍曲林治疗抑郁症近期疗效的随机双盲研究[J].中国新药杂志,1997,6(3):167-170. 被引量:6
  • 2[1]Preskorn SH.Comparison of the tolerability of bupropion,fluoxetine,imipramine,nefazodone,paroxetine,setraline and venlafaxine[J].J Clin psychiatry,1995,56(S6):12-21.
  • 3[2]Hyttel J.Pharmacological characterization of selective serotonin reuptakeinhibitiors (SSRIs)[J].Int Clin psychopharmacol,1994,9(S1):19-26.
  • 4[3]Thomas DR,Nelson DR,Johnson AM.Biochemical effects of the antidepressant paroxetine,a specific 5-hydroxytryptamine uptake inhibitor[J].Psychopharmacology,1987,93(2):193-200.
  • 5[4]Tulloch IF,Johnson AM.The pharmacologic profile of paroxetine,a new selective serotonin reuptake inhibitor[J].J Clin Psychiatry,1992,53(S2):7-12.
  • 6[5]Horton RW,DePawrmentier F,Lowther S,et al.The interaction of antidepressant drugs with neurotransmitter receptor binding sites and 5-HT uptake sites in human brain in vitro[J].European neuropsychopharmacology,1993,3(S1):344-345.
  • 7[6]Edwards JG,Anderson I.Systematic review and guide to selection of selective serotonin reuptake inhibitors[J].Drugs,1999,57(4):507-533.
  • 8[12]Anderson IM,Tomerson BM.Treatment discontinuation with selective serotonin reuotake inhibitors compared with tricyclic antidepressants:meta-analysis[J].BMJ,1995,310(6992):1433-1438.
  • 9[13]Montgomery SA,Kasper S.Comparison of compliance between selective serotonin reuptake inhibitors and tricyclic antidepressants:a meta-analysis[J].Int Clin Psychopharmacol,1995,9(S4):33-40.
  • 10[14]Vida S,Looper K.precision and comparability of adverse event rates of mewer antidepressants[J].J Clin Psychopharmacol,1999,19(5):416-426.

共引文献53

同被引文献70

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部